Elnaz Khani

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Coronavirus Disease

Acute Heart Failure

Glycemic Control

Systemic Lupus Erythematosus

Top Venues

International journal of surgery (London, England)

Clinical case reports

Journal of cardiovascular and thoracic research

Journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Fariba Pourkarim, Elnaz Khani, Leila Ghadakchi, Sanaz Ebrahimian
New-onset systemic lupus erythematosus after BBIBP-CorV vaccination. Clinical case reports 12 (2) (2024)
Fariba Pourkarim, Elnaz Khani, Leila Ghadakchi, Sanaz Ebrahimian
New-onset systemic lupus erythematosus after BBIBP-CorV vaccination. Clinical case reports 12 (2) (2024)
Hossein Namdar, Elnaz Khani, Sajad Khiali, Naser Safaie, Hedieh Ameli, Gholamreza Rahbari Banaeian, Taher Entezari-Maleki
Effects of citalopram on blood pressure control in depressive patients with hypertension: A randomized clinical trial. Journal of cardiovascular and thoracic research 16 (1) (2024)
Hossein Namdar, Elnaz Khani, Sajad Khiali, Naser Safaie, Hedieh Ameli, Gholamreza Rahbari Banaeian, Taher Entezari-Maleki
Effects of citalopram on blood pressure control in depressive patients with hypertension: A randomized clinical trial. Journal of cardiovascular and thoracic research 16 (1) (2024)
Mohammadreza Taban-Sadeghi, Elnaz Khani, Kimia Khezripour, Elgar Enamzadeh, Naser Safaei, Taher Entezari-Maleki
Effects of Triamterene in Hospitalized Patients with Heart Failure and Diuretic Resistance: A Randomized Clinical Trial. Journal of clinical pharmacology (2023)
Elnaz Khani, Taher Entezari-Maleki
Commentary on 'Implications of the SARS-CoV-2 subvariants BA.4 and BA.5'. International journal of surgery (London, England) 109 (1) (2023)
Elnaz Khani, Taher Entezari-Maleki
Commentary on 'Implications of the SARS-CoV-2 subvariants BA.4 and BA.5'. International journal of surgery (London, England) 109 (1) (2023)
Elnaz Khani, Taher Entezari-Maleki
Commentary on 'Implications of the SARS-CoV-2 subvariants BA.4 and BA.5'. International journal of surgery (London, England) 109 (1) (2023)
Elnaz Khani, Taher Entezari-Maleki
Commentary on 'Implications of the SARS-CoV-2 subvariants BA.4 and BA.5'. International journal of surgery (London, England) 109 (1) (2023)
Elnaz Khani, Taher Entezari-Maleki
Commentary on 'Implications of the SARS-CoV-2 subvariants BA.4 and BA.5'. International journal of surgery (London, England) 109 (1) (2023)
Sajad Khiali, Elnaz Khani, Samineh B Rouy, Taher Entezari-Maleki
Comprehensive review on molnupiravir in COVID-19: a novel promising antiviral to combat the pandemic. Future microbiology 17 (2022)
Elnaz Khani, Taher Entezari-Maleki
Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists. Molecular psychiatry 27 (9) (2022)